Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

Cited In for PubMed (Select 9738087)


How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?

Choi HY, Park HC, Ha SK.

Electrolyte Blood Press. 2014 Dec;12(2):41-54. doi: 10.5049/EBP.2014.12.2.41. Epub 2014 Dec 31. Review.


Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.

Alani H, Tamimi A, Tamimi N.

World J Nephrol. 2014 Nov 6;3(4):156-68. doi: 10.5527/wjn.v3.i4.156. Review.


Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Hecking M, Bieber BA, Ethier J, Kautzky-Willer A, Sunder-Plassmann G, Säemann MD, Ramirez SP, Gillespie BW, Pisoni RL, Robinson BM, Port FK.

PLoS Med. 2014 Oct 28;11(10):e1001750. doi: 10.1371/journal.pmed.1001750. eCollection 2014 Oct.


Combined effects of admission serum creatinine concentration with age and gender on the prognostic significance of subjects with acute ST-elevation myocardial infarction in China.

Li ZY, Pu-Liu, Chen ZH, An FH, Li LH, Li-Li, Guo CY, Gu Y, Liu Z, Zhu TB, Wang LS, Li CJ, Kong XQ, Ma WZ, Yang ZJ, Jia EZ.

PLoS One. 2014 Oct 10;9(10):e108986. doi: 10.1371/journal.pone.0108986. eCollection 2014.


Benefit of clopidogrel therapy in patients with myocardial infarction and chronic kidney disease-a Danish nation-wide cohort study.

Blicher TM, Hommel K, Kristensen SL, Torp-Pedersen C, Madsen M, Kamper AL, Olesen JB.

J Am Heart Assoc. 2014 Aug 21;3(4). pii: e001116. doi: 10.1161/JAHA.114.001116.


The link between chronic kidney disease and cardiovascular disease.

Said S, Hernandez GT.

J Nephropathol. 2014 Jul;3(3):99-104. doi: 10.12860/jnp.2014.19. Epub 2014 Jul 1. Review.


Chapter 2: Pharmacological cholesterol-lowering treatment in adults.

[No authors listed]

Kidney Int Suppl (2011). 2013 Nov;3(3):271-279. No abstract available.


Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease.

Jimbo R, Shimosawa T.

Int J Hypertens. 2014;2014:381082. doi: 10.1155/2014/381082. Epub 2014 Jan 12. Review.


Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction.

Zhao SL, Zhang YJ, Li MH, Zhang XL, Chen SL.

Stem Cell Res Ther. 2014 Mar 17;5(2):37. doi: 10.1186/scrt425.


Coronary artery disease in patients with chronic kidney disease: a clinical update.

Cai Q, Mukku VK, Ahmad M.

Curr Cardiol Rev. 2013 Nov;9(4):331-9. Review.


B-type natriuretic peptide and prognosis of end-stage renal disease: a meta-analysis.

Cheng YJ, Yao FJ, Liu LJ, Tang K, Lin XX, Li WJ, Zhang J, Wu SH.

PLoS One. 2013 Nov 13;8(11):e79302. doi: 10.1371/journal.pone.0079302. eCollection 2013.


Chronic kidney disease in acute coronary syndromes.

Marenzi G, Cabiati A, Assanelli E.

World J Nephrol. 2012 Oct 6;1(5):134-45. doi: 10.5527/wjn.v1.i5.134. Review.


Increased risk of mortality among haemodialysis patients with or without prior stroke: a nationwide population-based study in Taiwan.

Chien CC, Sun YM, Wang JJ, Chu CC, Lu CL, Wang SF, Hwang JC, Wang HY, Kan WC, Lu YH, Chen HA, Chio CC, Lin KC, Wu CC.

Indian J Med Res. 2013;138:232-8.


Association of systemic collagen type IV formation with survival among patients undergoing hemodialysis.

Leeming DJ, Karsdal MA, Rasmussen LM, Scholze A, Tepel M.

PLoS One. 2013 Aug 22;8(8):e71050. doi: 10.1371/journal.pone.0071050. eCollection 2013.


Clinical associations between renal dysfunction and vascular events: A literature review.

Karbasi-Afshar R, Saburi A, Taheri S.

ARYA Atheroscler. 2013 May;9(3):203-9.


Impaired kidney function at hospital discharge and long-term renal and overall survival in patients who received CRRT.

Stads S, Fortrie G, van Bommel J, Zietse R, Betjes MG.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1284-91. doi: 10.2215/CJN.06650712. Epub 2013 Apr 18.


A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study.

Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, Go AS, Hamm LL, Kusek JW, Ojo AO, Rahman M, Tao K, Wright JT, Xie D, Hsu CY; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2013 Mar;8(3):355-62. doi: 10.2215/CJN.06020612. Epub 2013 Feb 14.


Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.

Rangel-López A, Paniagua-Medina ME, Urbán-Reyes M, Cortes-Arredondo M, Alvarez-Aguilar C, López-Meza J, Ochoa-Zarzosa A, Lindholm B, García-López E, Paniagua JR.

Mutagenesis. 2013 Mar;28(2):219-25. doi: 10.1093/mutage/ges075.


Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.

Cavalca V, Veglia F, Squellerio I, De Metrio M, Rubino M, Porro B, Moltrasio M, Tremoli E, Marenzi G.

PLoS One. 2012;7(11):e48499. doi: 10.1371/journal.pone.0048499. Epub 2012 Nov 19.


Physical activity and blood lipids and lipoproteins in dialysis patients.

Imamura H, Mizuuchi K, Oshikata R.

Int J Nephrol. 2012;2012:106914. doi: 10.1155/2012/106914. Epub 2012 Sep 18.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk